The success of Viagra initially sparked a period of growth for pharma, however recent shifts present a murky picture for investors. Generic competitors are reducing profits, and persistent litigation add more risk to https://lilyrtng966556.59bloggers.com/41528270/sildenafil-and-big-pharma-a-risky-play